glaxosmithkline

Glaxosmithkline

Abbott (23)
Amgen (10)
Astra-merck (6)
Bayer (41)
Boehringer-ingelheim (1)
Bristol-myers-squibb (5)
Dupont-merck (14)
Eli lilly (5)
Genentech (5)
Genzyme (5)
Glaxosmithkline (26)
Hoechst-marion-roussel (4)
Pasteur-merieux (8)
Pfizer (22)
Pharmaceutical industry (36)
Pharmaceutical laboratory (1)
Pharmacyclics (1)
Roche pharmaceuticals (16)
Sanofi-aventis (6)
Stallergenes (1)
Whitehall laboratories (3)

Chris Corrigan lectures for Glaxosmithkline and Allergy Therapeutics and consults for Novartis Stallergenes and Allergy Therapeutics.

He has received funding from the Medical Research Council the Wellcome Trust Asthma UK Glaxosmithkline Allergopharma and various other charities

European Medicines Agency recommends approval of two H1n1 vaccines, from Novartis and Glaxosmithkline. 15 september 2009:

and zanamivir (marketed by Glaxosmithkline as Relenza), are effective against the new pandemic virus in human cells grown in the lab. These drugs are already being used to treat some infected patients.

Drug-maker Glaxosmithkline (GSK) was aware of cardiac risks associated with its diabetes drug Avandia (rosiglitazone) years before they became public

GSK says that the Senate report cherry-picked information and mischaracterized its efforts to research

London-based pharma giant Glaxosmithkline revealed plans on 4 february to shut down early-stage research into pain and depression medications,

Glaxosmithkline, Merck and Eli lilly already publicly report physician payments; this will be mandatory from 2013, under US health-care reform law.

Aspen, which is owned 19 by pharmaceutical giant Glaxosmithkline, headquartered in London, and is Africa's largest drugs manufacturer,

Red wine drug Drug company Glaxosmithkline (GSK) has halted all development of a proprietary formulation of resveratrol a chemical found in red wine

was being tested by GSK and its subsidiary, Sirtris in Cambridge, Massachusetts, against several conditions, including multiple myeloma.

But GSK, of London, has scuttled development of SRT501, it confirmed to the patient website Myeloma Beacon last week.

Business Avandia fine Drug giant Glaxosmithkline (GSK) announced on 3 november that it has agreed to pay US$3 billion to settle a bevy of US federal investigations into the way it has developed

when a US Senate committee concluded that GSK had known about the drug's heart risks for more than a decade without reporting them to regulators.

Pharma fines Drug giant Glaxosmithkline will pay US$3 billion in fines for enormous health-care fraud.

A company that later became part of Glaxosmithkline patented AZT in the 1980s when it was found to be effective against AIDS.

Pharma probe The Chinese government is investigating four senior executives of Glaxosmithkline (GSK) in China for allegedly bribing officials

and physicians to boost GSK drug sales, funnelling the money through travel agencies. The executives are suspected of giving 3 Â billion renminbi (US$489 Â million) in bribes since 2007

GSK, headquartered in London, says that it is conducting its own review and is cooperating with the Chinese police.

Most specifically the GSK paxil case wherein they used a ghostwriter to say the drug was safe.

The scientists found that apigenin inhibited an enzyme called glycogen synthase kinase-3î (GSK-3î) which led to a decrease in the production of anti-apoptotic genes in the pancreatic cancer cells.

and South africa thanks to a $400000 prize announced Nov 14 as part of the inaugural Healthcare Innovation Award program sponsored by pharmaceutical giant Glaxosmithkline and London-based nonprofit Save the Children.